Oculogenex

Peregrine Pharmaceuticals is a biopharmaceutical company with a portfolio of product candidates in clinical trials and pre-clinical development. Its products have a focus on the targeted treatment of cancer and viral diseases. The company s product candidates are Cotara and the Tarvacin line of products. Tarvacin Anti-Viral has been developed for the treatment of hepatitis C infection, influenza and other life-threatening viral infections. Tarvacin Anti-Cancer has been developed for the treatment of solid tumor cancers. The company s tumor necrosis therapy product, Cotara, has been developed to treat malignant brain cancer. Peregrine Pharmaceutical also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, which provides development and bio-manufacturing services for both Peregrine and outside customers. Peregrine Pharmaceuticals is headquartered in Tustin, Calif.

Vivosense, Inc. is a company based in Newport Coast, CA, specializing in transforming clinical trial portfolios through innovative digital measures. Their expert team is dedicated to understanding both present and future needs to deliver comprehensive solutions in clinical research. With a focus on designing, configuring, and generating insights, Vivosense emphasizes the importance of clean data collection and interpretation in clinical trials. They aim to facilitate meaningful conversations and foster collaboration among stakeholders to enhance the value of clinical research. Generated from the website

Myst Therapeutics, Inc. is a biotechnology company located in Los Angeles, CA, specializing in innovative therapeutic solutions. The company has recently announced its acquisition, highlighting its commitment to advancing healthcare through strategic partnerships. Established in 2019, Myst Therapeutics is focused on developing cutting-edge treatments that address unmet medical needs. Their vision is to leverage scientific advancements to improve patient outcomes in the field of therapeutics. Generated from the website